Supporting Uganda's Response to HIV/AIDS
A program description for the grant UGA-H-MoFPED has not been provided.
- ID Projet
47045-UGA-H-MoFPED
- Statut de l'activité
- 2 - Implementation
- Type d'aide
- C01 - Interventions de type projet
- % to Ouganda
- 100.00
Organisations
- Funding
- The Global Fund to Fight AIDS, Tuberculosis and Malaria
- Implementing
- Ministry of Finance, Planning and Economic Development of the Republic of Uganda
Versements par exercice fiscal, trimestre
Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Ouganda Montant (USD) |
2018 |
Q1 |
22,494,973.00 |
22,494,973.00 |
2017 |
Q4 |
14,866,489.00 |
14,866,489.00 |
2017 |
Q3 |
30,015,455.00 |
30,015,455.00 |
2017 |
Q2 |
2,382,369.00 |
2,382,369.00 |
2017 |
Q1 |
19,430,809.00 |
19,430,809.00 |
2016 |
Q4 |
13,898,745.00 |
13,898,745.00 |
2016 |
Q3 |
7,087,422.00 |
7,087,422.00 |
2016 |
Q2 |
21,302,279.00 |
21,302,279.00 |
2016 |
Q1 |
21,334,942.00 |
21,334,942.00 |
2015 |
Q4 |
101,670,539.00 |
101,670,539.00 |
2015 |
Q3 |
19,882,701.00 |
19,882,701.00 |
2015 |
Q2 |
96,407,074.00 |
96,407,074.00 |
2015 |
Q1 |
16,929,563.00 |
16,929,563.00 |
Engagements par exercice fiscal, trimestre
Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Ouganda Montant (USD) |
2018 |
Q1 |
4,054,725.00 |
4,054,725.00 |
2017 |
Q4 |
2,775,222.00 |
2,775,222.00 |
2017 |
Q3 |
68,975,513.00 |
68,975,513.00 |
2017 |
Q2 |
-175,494.00 |
-175,494.00 |
2017 |
Q1 |
12,164,896.00 |
12,164,896.00 |
2016 |
Q4 |
-1,866,461.00 |
-1,866,461.00 |
2016 |
Q3 |
5,183,158.00 |
5,183,158.00 |
2016 |
Q2 |
21,935,456.00 |
21,935,456.00 |
2016 |
Q1 |
11,130,632.00 |
11,130,632.00 |
2015 |
Q4 |
-349,079.00 |
-349,079.00 |
2015 |
Q3 |
4,586,336.00 |
4,586,336.00 |
2015 |
Q2 |
51,120,073.00 |
51,120,073.00 |
2015 |
Q1 |
108,878,720.00 |
108,878,720.00 |
Projections de CDMT par exercice fiscal
Exercice fiscal |
Montant (USD) |
Ouganda Montant (USD) |
2017 |
37,646,504.00 |
37,646,504.00 |
2016 |
67,164,352.00 |
67,164,352.00 |
2015 |
110,447,639.00 |
110,447,639.00 |
Code CRS |
% |
Lutte contre les MST et VIH/sida
(13040)
|
100.0
|